CalbaTech Contributes to key Effort Supporting Stem Cell Research to Cure Diabetes
News May 30, 2006
CalbaTech, Inc. has announced its stem cell subsidiary LifeStem, Inc. contributed five Stem Cell Microbank™ services to the Los Angeles chapter of the Juvenile Diabetes Research Foundation for its third annual gala "Finding A Cure: A Love Story Benefiting Stem Cell Research" held May 24th at the Beverly Hilton Hotel in Los Angeles.
This annual event benefits stem cell research with the potential to cure diabetes, plus other life threatening diseases including Alzheimer's, Parkinson's disease and Multiple Sclerosis.
Country music star Garth Brooks was honored with the Angel Award along with Steve and Ann Radar who received the Caregiver Award.
Country music singing star Trisha Yearwood was also in attendance. Previous award recipients at "Finding A Cure" include Nancy Reagan, James Taylor, Robin Williams, Michael J. Fox and Dana Reeve.
"We are delighted to have been part of this event and to contribute to its success," said CalbaTech CEO James DeOlden.
"Our subsidiary, LifeStem, which is overseeing the MicroBank™ Service, is the only company to collect and store adult stem cells from two different cell sources for possible future therapeutic uses."
"Someday we will look back on events like this and realize the importance of this early work on stem cell research in conquering some of mankind's most difficult diseases."
"With the research efforts by organizations such as JDRF to find cures through the use of stem cells, our Stem Cell Microbank™ Service may provide the vehicle for people who bank their stem to take advantage of such cures."
"We obviously believe that our Stem Cell Microbank™ Service complements the research efforts of JDRF, and others, and we applaud their tireless efforts."
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.